rethinkTHC Search
Menu
Study breakdown

Does CBD prevent psychosis-like behavior in mice through epigenetic changes?

Animal StudyPreliminary evidence
The takeaway

A mouse study found that CBD prevented disruptions in sensorimotor gating caused by psychosis-mimicking drugs, with effects lasting 24 hours and involving DNA methylation changes in the ventral striatum.

Researchers studying CBD mechanisms of action, and readers interested in how epigenetics may explain cannabis-related brain effects.

Effects lasted 24 hours; epigenetic changes detected

What the researchers found

CBD (30 and 60 mg/kg) attenuated amphetamine- and MK-801-induced disruption of prepulse inhibition, similar to clozapine. Amphetamine increased global DNA methylation in the ventral striatum, an effect prevented by CBD. CBD and clozapine both independently increased DNA methylation in the prefrontal cortex. CBD's antipsychotic-like effects persisted for 24 hours after a single dose.

Why it matters

This study suggests a novel mechanism for CBD's antipsychotic-like effects: modifying DNA methylation patterns. Epigenetic changes could explain why CBD effects outlast the drug's presence in the body and point toward longer-lasting therapeutic potential.

The numbers in context

CBD 30 and 60 mg/kg both effective; clozapine 5 mg/kg as comparator; amphetamine 5 mg/kg and MK-801 0.5 mg/kg as psychosis models; effects detectable 24 hours after single dose; DNA methylation changes in ventral striatum and prefrontal cortex

How the study worked

Controlled animal study in mice using the prepulse inhibition (PPI) model. Tested single injections of CBD (30 or 60 mg/kg) or clozapine (5 mg/kg) followed by amphetamine (5 mg/kg) or MK-801 (0.5 mg/kg). Assessed PPI disruption and global DNA methylation in ventral striatum and prefrontal cortex via Western blot.

What this study cannot tell us

Animal study with limited translatability. Global DNA methylation is a blunt measure that does not identify which specific genes are affected. PPI disruption is a proxy for sensorimotor gating deficits in schizophrenia but does not model the full disorder.

How to read the evidence

Well-controlled animal study with appropriate pharmacological comparators, but preclinical only with a blunt epigenetic measure.

When this study was published

Published in 2021; epigenetic mechanisms of cannabinoids remain a relatively new research area.

The bigger picture

Epigenetic mechanisms like DNA methylation can produce lasting changes in gene expression without altering DNA sequence. If CBD works partly through epigenetic modification, it could explain sustained benefits and distinguish it from conventional antipsychotics that primarily work through receptor blockade.

Questions still open

  • Which specific genes are affected by CBD-induced DNA methylation changes? Does repeated CBD dosing produce cumulative epigenetic effects? Could epigenetic markers serve as biomarkers for CBD response in psychosis patients?

Common questions

What are epigenetic changes?
Epigenetic changes modify how genes are expressed without changing the DNA sequence itself. DNA methylation, which this study measured, can turn genes on or off. These changes can be longer-lasting than typical drug effects.
How does this relate to treating schizophrenia?
The study used established animal models of psychosis and found CBD worked as well as the antipsychotic clozapine at preventing symptoms, while also modifying DNA methylation in brain regions involved in schizophrenia. This suggests a potential new mechanism for antipsychotic effects.

Read the original research

Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum.

Progress in neuro-psychopharmacology & biological psychiatry, 111, 110352

Citation

Pedrazzi, João F C; Sales, Amanda J; Guimarães, Francisco S; Joca, Sâmia R L; Crippa, José A S; Del Bel, Elaine. (2021). Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum.. Progress in neuro-psychopharmacology & biological psychiatry, 111, 110352. https://doi.org/10.1016/j.pnpbp.2021.110352

Explore the wider topic